JP2024501063A - 循環転写因子の分析 - Google Patents

循環転写因子の分析 Download PDF

Info

Publication number
JP2024501063A
JP2024501063A JP2023539832A JP2023539832A JP2024501063A JP 2024501063 A JP2024501063 A JP 2024501063A JP 2023539832 A JP2023539832 A JP 2023539832A JP 2023539832 A JP2023539832 A JP 2023539832A JP 2024501063 A JP2024501063 A JP 2024501063A
Authority
JP
Japan
Prior art keywords
dna
transcription factor
subject
fragments
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023539832A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024501063A5 (https=
Inventor
ビンセント ミカレフ ジャコブ
エドワード エクルストン マーク
フェルナンド フランソワ パマート ドリアン
ヘルツォーク マリエール
Original Assignee
ベルジアン ボリション エスアールエル
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ベルジアン ボリション エスアールエル filed Critical ベルジアン ボリション エスアールエル
Publication of JP2024501063A publication Critical patent/JP2024501063A/ja
Publication of JP2024501063A5 publication Critical patent/JP2024501063A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6804Nucleic acid analysis using immunogens
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2535/00Reactions characterised by the assay type for determining the identity of a nucleotide base or a sequence of oligonucleotides
    • C12Q2535/122Massive parallel sequencing
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2545/00Reactions characterised by their quantitative nature
    • C12Q2545/10Reactions characterised by their quantitative nature the purpose being quantitative analysis
    • C12Q2545/114Reactions characterised by their quantitative nature the purpose being quantitative analysis involving a quantitation step
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2563/00Nucleic acid detection characterized by the use of physical, structural and functional properties
    • C12Q2563/131Nucleic acid detection characterized by the use of physical, structural and functional properties the label being a member of a cognate binding pair, i.e. extends to antibodies, haptens, avidin
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/52Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Analysing Materials By The Use Of Radiation (AREA)
JP2023539832A 2020-12-29 2021-12-29 循環転写因子の分析 Pending JP2024501063A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063131722P 2020-12-29 2020-12-29
US63/131,722 2020-12-29
PCT/EP2021/087813 WO2022144407A1 (en) 2020-12-29 2021-12-29 Circulating transcription factor analysis

Publications (2)

Publication Number Publication Date
JP2024501063A true JP2024501063A (ja) 2024-01-10
JP2024501063A5 JP2024501063A5 (https=) 2025-01-14

Family

ID=79927307

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023539832A Pending JP2024501063A (ja) 2020-12-29 2021-12-29 循環転写因子の分析

Country Status (11)

Country Link
US (1) US20240318226A1 (https=)
EP (1) EP4271833A1 (https=)
JP (1) JP2024501063A (https=)
KR (1) KR20230132485A (https=)
CN (1) CN116917496A (https=)
AU (1) AU2021414296A1 (https=)
CA (1) CA3206465A1 (https=)
IL (1) IL303977A (https=)
MX (1) MX2023007818A (https=)
TW (1) TW202242130A (https=)
WO (1) WO2022144407A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115851951A (zh) * 2022-12-12 2023-03-28 广州优泽生物技术有限公司 含多组学标志物组合物的早期肝癌检测模型构建及试剂盒
WO2024133222A1 (en) * 2022-12-19 2024-06-27 Belgian Volition Srl Assessment of biological samples for nucleic acid analysis
GB202303562D0 (en) * 2023-03-10 2023-04-26 Belgian Volition Sprl Sample collection for liquid biopsy
WO2025073909A1 (en) 2023-10-04 2025-04-10 Belgian Volition Srl Pcr method for detecting ctcf occupied cfdna fragments

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2019510974A (ja) * 2016-03-22 2019-04-18 ベルジアン ボリション エスピーアールエル 癌検出のためのヌクレオソーム−転写因子複合体の使用
WO2019175876A2 (en) * 2018-03-13 2019-09-19 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Diagnostic use of cell free dna chromatin immunoprecipitation
US20190284603A1 (en) * 2015-08-21 2019-09-19 The General Hospital Corporation Combinatorial single molecule analysis of chromatin
WO2020206143A1 (en) * 2019-04-05 2020-10-08 Claret Bioscience, Llc Methods and compositions for analyzing nucleic acid

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0319376D0 (en) 2003-08-18 2003-09-17 Chroma Therapeutics Ltd Histone modification detection
GB201115098D0 (en) 2011-09-01 2011-10-19 Belgian Volition Sa Method for detecting nucleosomes containing histone variants
GB201115095D0 (en) 2011-09-01 2011-10-19 Singapore Volition Pte Ltd Method for detecting nucleosomes containing nucleotides
PT2788767T (pt) 2011-12-07 2017-12-06 Belgian Volition Sprl Método de detecção de adutos de nucleosoma
IL305462A (en) 2015-07-23 2023-10-01 Univ Hong Kong Chinese DNA fragmentation pattern analysis suitable clean
LT3334841T (lt) * 2015-08-12 2020-02-10 Cemm - Forschungszentrum Für Molekulare Medizin Gmbh Nukleorūgščių tyrimo būdai

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20190284603A1 (en) * 2015-08-21 2019-09-19 The General Hospital Corporation Combinatorial single molecule analysis of chromatin
JP2019510974A (ja) * 2016-03-22 2019-04-18 ベルジアン ボリション エスピーアールエル 癌検出のためのヌクレオソーム−転写因子複合体の使用
WO2019175876A2 (en) * 2018-03-13 2019-09-19 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Diagnostic use of cell free dna chromatin immunoprecipitation
WO2020206143A1 (en) * 2019-04-05 2020-10-08 Claret Bioscience, Llc Methods and compositions for analyzing nucleic acid

Also Published As

Publication number Publication date
KR20230132485A (ko) 2023-09-15
MX2023007818A (es) 2023-09-05
WO2022144407A1 (en) 2022-07-07
CA3206465A1 (en) 2022-07-07
AU2021414296A1 (en) 2023-07-27
CN116917496A (zh) 2023-10-20
IL303977A (en) 2023-08-01
TW202242130A (zh) 2022-11-01
EP4271833A1 (en) 2023-11-08
US20240318226A1 (en) 2024-09-26

Similar Documents

Publication Publication Date Title
US11193939B2 (en) Method for detecting nucleosome adducts
JP2024501063A (ja) 循環転写因子の分析
CN114901832A (zh) 分离循环核小体的方法
US20240318255A1 (en) Transcription factor binding site analysis of nucleosome depleted circulating cell free chromatin fragments
JP6777757B2 (ja) 癌検出のためのヌクレオソーム−転写因子複合体の使用
EA052463B1 (ru) Анализ циркулирующих факторов транскрипции
WO2025073909A1 (en) Pcr method for detecting ctcf occupied cfdna fragments
HK40055426A (en) Use of dna-transcription factor complexes for cancer detection
HK40003771B (en) Use of nucleosome-transcription factor complexes for cancer detection

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20231006

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20241225

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20241225

RD13 Notification of appointment of power of sub attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7433

Effective date: 20250926

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20251218

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20260106

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20260403